{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:29:03Z","timestamp":1790908143123,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1097\/cco.0b013e3282ce6f8f","type":"journal-article","created":{"date-parts":[[2007,8,6]],"date-time":"2007-08-06T07:04:46Z","timestamp":1186383886000},"page":"438-443","source":"Crossref","is-referenced-by-count":27,"title":["Management of peripheral T-cell non-Hodgkin's lymphoma"],"prefix":"10.1097","volume":"19","author":[{"given":"Steven M","family":"Horwitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210128","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1001\/jama.295.24.2836","article-title":"Rare disease research gets boost","volume":"295","author":"Hampton","year":"2006","journal-title":"JAMA"},{"key":"R2-4-20210128","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes","volume":"16","author":"Armitage","year":"1998","journal-title":"J Clin Oncol"},{"key":"R3-4-20210128","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995","volume":"92","author":"Groves","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R4-4-20210128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"R5-4-20210128","article-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours","author":"Jaffe","year":"2001"},{"key":"R6-4-20210128","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"key":"R7-4-20210128","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R8-4-20210128","first-page":"4952","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Am Soc Hematol"},{"key":"R9-4-20210128","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","article-title":"Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets","volume":"117","author":"Piccaluga","year":"2007","journal-title":"J Clin Invest"},{"key":"R10-4-20210128","doi-asserted-by":"crossref","first-page":"a811","DOI":"10.1182\/blood.V106.11.811.811","article-title":"International peripheral T-cell lymphoma (PTCL) clinical and pathologic review project: poor outcome by prognostic indices and lack of efficacy with anthracyclines [abstract]","volume":"106","author":"Vose","year":"2005","journal-title":"Blood"},{"key":"R11-4-20210128","doi-asserted-by":"crossref","first-page":"a2399","DOI":"10.1182\/blood.V108.11.2399.2399","article-title":"FDG-PET scans as a staging study for T-cell lymphomas: high rates of positivity do not result in frequent changes in stage [abstract]","volume":"108","author":"Horwitz","year":"2006","journal-title":"Blood"},{"key":"R12-4-20210128","first-page":"1622","article-title":"18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease","volume":"47","author":"Hadithi","year":"2006","journal-title":"J Nucl Med"},{"key":"R13-4-20210128","first-page":"76","article-title":"Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)","volume":"92","author":"Gisselbrecht","year":"1998","journal-title":"Blood"},{"key":"R14-4-20210128","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","article-title":"Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification","volume":"9","author":"L\u00f3pez-Guillermo","year":"1998","journal-title":"Ann Oncol"},{"key":"R15-4-20210128","first-page":"2474","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Am Soc Hematol"},{"key":"R16-4-20210128","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"},{"key":"R17-4-20210128","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","article-title":"Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification","volume":"15","author":"Savage","year":"2004","journal-title":"Ann Oncol"},{"key":"R18-4-20210128","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma. A review of 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"key":"R19-4-20210128","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic \u03b3\u03b4 T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"R20-4-20210128","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/cncr.20999","article-title":"Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the MD Anderson Cancer Center experience","volume":"103","author":"Escal\u00f3n","year":"2005","journal-title":"Cancer"},{"key":"R21-4-20210128","doi-asserted-by":"crossref","first-page":"a2464","DOI":"10.1182\/blood.V108.11.2464.2464","article-title":"The VIP-ABVD regimen is not superior to the CHOP 21 for the treatment of non epidermotropic peripheral T cell lymphoma. Final results of the LTP95 protocol of the GOELAMS [abstract]","volume":"108","author":"Gressin","year":"2006","journal-title":"Blood"},{"key":"R22-4-20210128","doi-asserted-by":"crossref","first-page":"a401","DOI":"10.1182\/blood.V108.11.401.401","article-title":"Dose-dense induction followed by autologous stem cell transplant (ASCT) as 1st line treatment in peripheral T-cell lymphomas (PTCL): a phase II study of the Nordic Lymphoma Group (NLG) [abstract]","volume":"108","author":"d'Amore","year":"2006","journal-title":"Blood"},{"key":"R23-4-20210128","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","article-title":"Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation","volume":"20","author":"Corradini","year":"2006","journal-title":"Leukemia"},{"key":"R24-4-20210128","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/annonc\/mdl466","article-title":"The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience","volume":"18","author":"Rodr\u00edguez","year":"2007","journal-title":"Ann Oncol"},{"key":"R25-4-20210128","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2141.2006.06164.x","article-title":"Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma","volume":"134","author":"Kewalramani","year":"2006","journal-title":"Br J Haematol"},{"key":"R26-4-20210128","first-page":"1372","article-title":"High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience","volume":"88","author":"Rodriguez","year":"2003","journal-title":"J Hematol"},{"key":"R27-4-20210128","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.bmt.1702867","article-title":"High dose therapy and autologous stem cell transplantation in patients with peripheral T-cell lymphomas","volume":"27","author":"Blystad","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R28-4-20210128","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2001.19.17.3766","article-title":"Impact of high-dose chemotherapy on peripheral T-cell lymphomas","volume":"19","author":"Rodriguez","year":"2001","journal-title":"J Clin Oncol"},{"key":"R29-4-20210128","doi-asserted-by":"crossref","first-page":"a2679","DOI":"10.1182\/blood.V106.11.2679.2679","article-title":"Second-line therapy with ICE followed by high dose therapy and autologous stem cell transplantation for relapsed\/refractory peripheral T-cell lymphomas: minimal benefit when analyzed by intent to treat [abstract]","volume":"106","author":"Horwitz","year":"2005","journal-title":"Blood"},{"key":"R30-4-20210128","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","article-title":"Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells","volume":"22","author":"Corradini","year":"2004","journal-title":"J Clin Oncol"},{"key":"R31-4-20210128","doi-asserted-by":"crossref","first-page":"a8095","DOI":"10.1200\/jco.2007.25.18_suppl.8095","article-title":"Allogeneic stem cell transplantation (allo-SCT) in T-cell lymphomas: a French national survey from the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle et de Th\u00e9rapie Cellulaire (SFGM-TC) [abstract]","volume":"25","author":"le Gouill","year":"2007","journal-title":"J Clin Oncol"},{"key":"R32-4-20210128","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2141.2006.06457.x","article-title":"Phase II trial of denileukin diftitox for relapsed\/refractory T-cell non-Hodgkin lymphoma","volume":"136","author":"Dang","year":"2006","journal-title":"BJH"},{"key":"R33-4-20210128","first-page":"a3057","article-title":"Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-cell lymphomas: results of the MSKCC phase I\/II experience [abstract]","volume":"108","author":"O'Connor","year":"2006","journal-title":"Blood"},{"key":"R34-4-20210128","doi-asserted-by":"crossref","first-page":"a8027","DOI":"10.1200\/jco.2007.25.18_suppl.8027","article-title":"Update of the NCI multiinstitutional phase II trial of romidepsin, FK228, for patients with cutaneous or peripheral T-cell lymphoma [abstract]","volume":"25","author":"Piekarz","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0b013e3282ce6f8f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:06:22Z","timestamp":1620950782000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001622-200709000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0b013e3282ce6f8f","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}